Niklas Dienstbier

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal Cancer

Jörn Weisner, Ina Landel, Christoph Reintjes et al. · Cancer Research · 2019 · 88 citations

Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity

Laura Sinatra, Jing Yang, Julian Schliehe‐Diecks et al. · Journal of Medicinal Chemistry · 2022 · 63 citations · Full text

Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization

Sanil Bhatia, Lukas V. Spanier, David Bickel et al. · ACS Central Science · 2022 · 34 citations · Full text

Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells

Melina Vogt, Niklas Dienstbier, Julian Schliehe‐Diecks et al. · Cell Death and Disease · 2023 · 16 citations · Full text

Development of the first geldanamycin-based HSP90 degraders

Silas Wurnig, Melina Vogt, Julian Hogenkamp et al. · Frontiers in Chemistry · 2023 · 11 citations · Full text